Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

(2016) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Risk Stratification for Primary Prevention Implantable Cardioverter DefibrillatorsCLINICAL PERSPECTIVE

(2015) Douglas S. Lee et al.   Circulation-Heart Failure

Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry

(2015) Avi Sabbag et al.   HEART RHYTHM

The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy

(2013) M. Disertori et al.   EUROPACE

2013 ACCF/AHA Guideline for the Management of Heart Failure

(2013) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis

(2012) T. Smith et al.   EUROPEAN HEART JOURNAL

Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score

(2012) Johannes B van Rees et al.   HEART

Non–Evidence-Based ICD Implantations in the United States

(2011) Sana M. Al-Khatib   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Inappropriate Implantable Cardioverter-Defibrillator Shocks

(2011) Johannes B. van Rees et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator

(2010) Ilan Goldenberg et al.   CIRCULATION

Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest?

(2010) F. A. L. E. Bracke et al.   Netherlands Heart Journal

Registries and Selection Bias

(2009) Harlan M. Krumholz  

Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population

(2009) Martin R. Cowie et al.   EUROPACE

Are complications of implantable defibrillators under-estimated and benefits over-estimated?

(2009) M. Brignole   EUROPACE

Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy

(2008) Michael T. Koller et al.   CIRCULATION

Design and implementation of a population-based registry of implantable cardioverter defibrillators (ICDs) in Ontario

(2008) Douglas S. Lee et al.   HEART RHYTHM

Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction

(2008) Ilan Goldenberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death

(2008) Roderick Tung et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure

(2008) Jeanne E. Poole et al.   NEW ENGLAND JOURNAL OF MEDICINE